Mechanism of action of quinolones against Escherichia coli DNA gyrase
- 1 April 1993
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (4) , 839-845
- https://doi.org/10.1128/aac.37.4.839
Abstract
The mechanism of action of quinolones was investigated by use of various DNA gyrases reconstituted from wild-type and mutant GyrA and GyrB proteins of Escherichia coli. The quinolone sensitivities of the DNA supercoiling activity of the gyrases were generally parallel to the quinolone susceptibilities of strains having the corresponding enzymes and depended on gyrase subunits but not on substrate DNA. [3H]Enoxacin did not bind to gyrase alone or DNA alone but bound to gyrase-DNA complexes when measured by a gel filtration method. There appeared to be two enoxacin binding phases, at low and high enoxacin concentrations, for the wild-type gyrase-DNA and type 2 GyrB (Lys-447 to Glu) mutant gyrase-DNA complexes but only one enoxacin binding phase at the concentrations used for the GyrA (Ser-83 to Leu) mutant gyrase-DNA and type 1 GyrB (Asp-426 to Asn) mutant gyrase-DNA complexes. New enoxacin binding sites appeared in the presence of enoxacin, and the enoxacin binding affinities for the sites, especially at low enoxacin concentrations, near the MICs for the strains having the corresponding gyrases, correlated well with the enoxacin sensitivities of the gyrases and the MICs. From the results obtained, we propose a quinolone pocket model as the mechanism of action of quinolones, in which quinolones exert their action through binding to a gyrase-DNA complex and the quinolone binding affinities for the complex are determined by both GyrA and GyrB subunits in concert.Keywords
This publication has 25 references indexed in Scilit:
- Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1990
- Pyridonecarboxylic acids as antibacterial agents. Part 14. Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potencyJournal of Medicinal Chemistry, 1990
- Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding modelBiochemistry, 1989
- gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coliAntimicrobial Agents and Chemotherapy, 1989
- Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coliAntimicrobial Agents and Chemotherapy, 1986
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- 1,4-Dihydro-4-oxopyridinecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agentJournal of Medicinal Chemistry, 1984
- DNA TopoisomerasesAnnual Review of Biochemistry, 1981
- Deoxyribonucleic acidgyrase-deoxyribonucleic acid complex containing 140 base pairs of deoxyribonucleic acid and an .alpha.2.beta.2 protein coreBiochemistry, 1980
- Quinoline antibacterial agents. Oxolinic acid and related compoundsJournal of Medicinal Chemistry, 1968